Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Adrenaline Aguettant 1:10,000
Active Ingredient:	Adrenaline acid tartrate 1.1819mg/mL equivalent to adrenaline 1mg
Dosage Form:	Solution for injection
New Zealand Sponsor:	Juno Pharmaceuticals NZ Limited
Manufacturer:	Laboratoire Aguettant SA, Lyon, France

*Product:*	Brimonidine Timolol Indoco
Active Ingredients:	Brimonidine tartrate 2mg/mL Timolol maleate 6.8mg/mL equivalent to timolol 5mg/mL
Dosage Form:	Eye drops, solution
New Zealand Sponsor:	Miro Healthcare Limited
Manufacturer:	Indoco Remedies Limited, Verna, India

*Product:*	Chlorhexidine 0.2% Mouthwash
Active Ingredient:	Chlorhexidine gluconate 10g/L
Dosage Form:	Mouthwash
New Zealand Sponsor:	Jaychem Industries Limited
Manufacturer:	Jaychem Industries Limited, Auckland, New Zealand

*Product:*	Deep Heat Night Soothe
Active Ingredients:	Menthol 80mg/g Methyl salicylate 250mg/g
Dosage Form:	Topical cream
New Zealand Sponsor:	Ebos Group Limited
Manufacturer:	Mentholatum Australasia Pty Limited, Melbourne, Australia

*Product:*	Hyrimoz
Active Ingredient:	Adalimumab 50mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Novartis New Zealand Limited
Manufacturer:	Sandoz GmbH, Langkampfen, Austria

Dated this 20th day of December 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule